Chemoinformaics analysis of 1,3,8-Trihydroxy-2-methylanthracene-9,10-dione
| Molecular Weight | 270.24 | nRot | 0 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 18 |
| Exact Molecular Weight | 270.053 | nRing | 3 |
| Solubility: LogS | -4.396 | nHRing | 0 |
| Solubility: LogP | 3.7 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 35.7279 |
| nHD | 3 | BPOL | 11.7681 |
| QED | 0.579 |
| Synth | 2.395 |
| Natural Product Likeliness | 1.624 |
| NR-PPAR-gamma | 0.959 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.067 |
| Pgp-sub | 0.001 |
| HIA | 0.027 |
| CACO-2 | -5.13 |
| MDCK | 0.0000123 |
| BBB | 0.05 |
| PPB | 1.0017 |
| VDSS | 0.404 |
| FU | 0.0103382 |
| CYP1A2-inh | 0.911 |
| CYP1A2-sub | 0.208 |
| CYP2c19-inh | 0.096 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.62 |
| CYP2c9-sub | 0.279 |
| CYP2d6-inh | 0.264 |
| CYP2d6-sub | 0.165 |
| CYP3a4-inh | 0.459 |
| CYP3a4-sub | 0.14 |
| CL | 8.545 |
| T12 | 0.222 |
| hERG | 0.013 |
| Ames | 0.877 |
| ROA | 0.12 |
| SkinSen | 0.782 |
| Carcinogencity | 0.82 |
| EI | 0.964 |
| Respiratory | 0.052 |
| NR-Aromatase | 0.632 |
| Antiviral | Yes |
| Prediction | 0.699792 |